Patente

  1. M. Garbarg, J.-M. Arrang, W. Schunack, R. LIpp, H. Stark, J.-M. Lecomte and J.-C. Schwartz, Nouveaux composés agonistes du récepteur H3 de l'histamine á usage thérapeutique, compositions pharmaceutiques agissant comme agonistes dudit récepteur et procédé de preparation.
    FR 2 661 909
    WO 91/17 146
    US 5,342,960
    EP 0 482 183
    CA 20 63 550
    JP 06/501 241
    JP 30 94 384
    GR
    3024991 T
    DE 69 127 045
    ES 21 07 464
    AT 0156 121
    DK 0482 183


  2. J.-C. Schwartz, J.-M. Arrang, M. Garbarg, J.-M. .Lecomte, C.R. Ganellin, A. Fkyerat, W. Tertiuk, W. Schunack, R. Lipp, H. Stark, and K. Purand, Antagonistes du récepteur H3 de l'histamine á usage thérapeutique et le procédé de preparation.
    FR 26 86 084
    WO 93/14 070
    US 5,559 113
    , US RE37,303
    CA 21 05 867
    EP 05 97 088
    JP6506003
    ; JP 38292259.
    US 5,708 171
    DE 69 32 97 27
    ES 212 54 270
    DK 597 088
    AT 197
    PT 597088
    GR 3035414


  3. J.-C. Schwartz, J.-M. Arrang, M. Garbarg, A. Quemener, J.-M. Lecomte, X. Ligneau, W. Schunack, H. Stark, K. Purand, A, Hüls, S. Reidemeister, S. Athmani, C. R. Ganellin, N. Pelloux-Léon, W. Tertiuk, M. C. O. Krause, and B. Sadek,
    Nouveaux dérivés de l´imidazole antagonistes et/ou agonistes du récepteur H3 de l´histamine, leur préparation et leurs applications thérapeutiques.
    FR 02 732 0).
    WO 96/29 315
    EP 076 081 1
    US 6,248,765
    CA
    2.190.865
    MX 965 687
    JP 10501001


  4. J.-C. Schwartz, J.-M. Arrang, M. Garbarg, J.-M. Lecomte, X. Ligneau, W. Schunack, H. Stark, C. R. Ganellin, F. Leurquin, and S. Elz.
    Non-imidazole Aryloxy (or Arylthio) Alkylamines as Histamine H3-Receptor Antagonists and Their Therapeutic Applications.
    EP 0 978 512


  5. J.-C. Schwartz, J.-M. Arrang, M. Garbarg, J.-M. Lecomte, X. Ligneau, W. Schunack, H. Stark, C. R. Ganellin, F. Leurquin, and S. Elz.
    Non-imidazole Alkylamines as Histamine H3-Receptor Ligands and Their Therapeutic Applications.
    EP 0 982 300
    WO 00/06254
    AU 55 11 999
    US 7,169,928
    , US 7169928, US 2004 220 225; US 7138413
    CA 2.321.881
    JP 2002521463
    EP 1 100
    EP 1 428 820
    DK 1100503
    AT 276751
    DE 69920472T
    ES 2226423
    PT 1100503T.
    DE 69931409
    DK 1428820
    AT 326446
    EP 1428820
    ES 2260703
    PT 1428820
    US 2006247223


  6. M. Raga, J. Sallares, M. Guerriero, A. Guglietta, J.-C. Schwartz, J.-M. Lecomte, W. Schunack, J.-M. Arrang, X. Ligneau, H. Stark, and C. R. Ganellin. (Formerly: Ferrer International, S. A.; now: Bioprojet).
    Monohydrochloride salt of 1-[3-[3-(4chlorophenyl)propoxy]propyl]-piperidine.
    EP 06708050.7
    AR 054734
    EP 1846384
    CA 2597016
    UY29369
    KR20070101381
    AT 391716
    AT 402154
    CN 101155793
    JP 2007554541
    US2008221162
    HR P20080446
    DK 1846384
    SI 1846384
    PT1846384
    MX20070101381
    ES2309948


  7. J. Sallares, I. Petschen, X. Camps, W. Schunack, H. Stark, and M. Capet (Bioprojet (Ferrer International, S. A.)).
    Process for preparing 1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine.
    EP 1910323
    WO 2007006708
    AR 054530


  8. H. Stark, J. M. Leppanen, B. C. Sasse, O. Saur, T. Kottke, and M. P. Hill.
    Medicaments (Preparation of 6-amino-4,5,6,7-tetrahydrobenzthiazole derivatives and related analogous as dopamine receptor agonists for treating Parkinson´s disease).
    WO 2009 056805
    GB 20070021333


  9. H. Stark, J. M. Leppanen, B. C. Sasse, O. Saur, T. Kottke, and M. P. Hill.
    Medicaments (Preparation of 6-amino-4,5,6,7-tetrahydrobenzthiazole derivatives as dopamine receptor ligands).
    WO 2009 056811
    GB 20070021332


  10. H. Stark, A. Zivkovic, A. Huwiler, and J. Pfeilschifter.
    Novel Sphingolipid Heterocyclic Compounds as Modulators of Sphingolipid Signaling and Uses Thereof.
    EP Appl. 11160903.8
    EP Appl. 2012 055980

Verantwortlich für den Inhalt: E-Mail sendenPeter Sippel